Journey Medical (DERM) Amortization of Deferred Charges (2020 - 2026)
Journey Medical (DERM) posted Amortization of Deferred Charges of $23000.0 for Q1 2026, little changed on a QoQ basis from $23000.0 in Q4 2025, and up 9.52% year-over-year from $21000.0 in Q1 2025.
Journey Medical (DERM) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Journey Medical's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $23000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges rose 9.52% year-over-year to $23000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $88000.0, down 3.3% from the prior year.
- Amortization of Deferred Charges was $23000.0 for Q1 2026 at Journey Medical, roughly flat from $23000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $24000.0 in Q2 2024 and bottomed at $21000.0 in Q4 2022.
- A 5-year average of $22235.3 and a median of $22000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2024 — Amortization of Deferred Charges advanced 14.29% — and 2025, when it decreased 8.33%.
- Journey Medical's Amortization of Deferred Charges stood at $21000.0 in 2022, then increased by 9.52% to $23000.0 in 2023, then decreased by 4.35% to $22000.0 in 2024, then gained by 4.55% to $23000.0 in 2025, then changed by 0.0% to $23000.0 in 2026.
- Business Quant data shows DERM's Amortization of Deferred Charges at $23000.0 in Q1 2026, $23000.0 in Q4 2025, and $22000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Dec 31, 2023 | 23,000.00 |